Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14

Upton, Kristen ; Meyers, Matthew ; Thorsell, Ann-Gerd ; Karlberg, Tobias LU ; Holechek, Jacob ; Lease, Robert ; Schey, Garrett ; Wolf, Emily ; Lucente, Adrianna and Schüler, Herwig LU orcid , et al. (2017) In Bioorganic & Medicinal Chemistry Letters 27(13). p.2907-2911
Abstract

A series of (Z)-4-(3-carbamoylphenylamino)-4-oxobut-2-enyl amides were synthesized and tested for their ability to inhibit the mono-(ADP-ribosyl)transferase, PARP14 (a.k.a. BAL-2; ARTD-8). Two synthetic routes were established for this series and several compounds were identified as sub-micromolar inhibitors of PARP14, the most potent of which was compound 4t, IC50=160nM. Furthermore, profiling other members of this series identified compounds with >20-fold selectivity over PARP5a/TNKS1, and modest selectivity over PARP10, a closely related mono-(ADP-ribosyl)transferase.

Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
keywords
Dose-Response Relationship, Drug, Drug Design, Humans, Models, Molecular, Molecular Structure, Poly(ADP-ribose) Polymerase Inhibitors/chemistry, Poly(ADP-ribose) Polymerases/metabolism, Structure-Activity Relationship
in
Bioorganic & Medicinal Chemistry Letters
volume
27
issue
13
pages
5 pages
publisher
Elsevier
external identifiers
  • pmid:28495083
  • scopus:85019026432
ISSN
0960-894X
DOI
10.1016/j.bmcl.2017.04.089
language
English
LU publication?
no
additional info
Copyright © 2017 Elsevier Ltd. All rights reserved.
id
a5467934-a5b3-429a-bd72-8344cf6832c2
date added to LUP
2024-11-21 17:51:07
date last changed
2025-05-09 22:31:19
@article{a5467934-a5b3-429a-bd72-8344cf6832c2,
  abstract     = {{<p>A series of (Z)-4-(3-carbamoylphenylamino)-4-oxobut-2-enyl amides were synthesized and tested for their ability to inhibit the mono-(ADP-ribosyl)transferase, PARP14 (a.k.a. BAL-2; ARTD-8). Two synthetic routes were established for this series and several compounds were identified as sub-micromolar inhibitors of PARP14, the most potent of which was compound 4t, IC50=160nM. Furthermore, profiling other members of this series identified compounds with &gt;20-fold selectivity over PARP5a/TNKS1, and modest selectivity over PARP10, a closely related mono-(ADP-ribosyl)transferase.</p>}},
  author       = {{Upton, Kristen and Meyers, Matthew and Thorsell, Ann-Gerd and Karlberg, Tobias and Holechek, Jacob and Lease, Robert and Schey, Garrett and Wolf, Emily and Lucente, Adrianna and Schüler, Herwig and Ferraris, Dana}},
  issn         = {{0960-894X}},
  keywords     = {{Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Poly(ADP-ribose) Polymerase Inhibitors/chemistry; Poly(ADP-ribose) Polymerases/metabolism; Structure-Activity Relationship}},
  language     = {{eng}},
  month        = {{07}},
  number       = {{13}},
  pages        = {{2907--2911}},
  publisher    = {{Elsevier}},
  series       = {{Bioorganic & Medicinal Chemistry Letters}},
  title        = {{Design and synthesis of potent inhibitors of the mono(ADP-ribosyl)transferase, PARP14}},
  url          = {{http://dx.doi.org/10.1016/j.bmcl.2017.04.089}},
  doi          = {{10.1016/j.bmcl.2017.04.089}},
  volume       = {{27}},
  year         = {{2017}},
}